Z-103 Phase III Clinical Study in patients with Taste Disorder - A placebo-controlled superiority study
Phase 3
- Conditions
- taste disorders induced by zinc-deficiency
- Registration Number
- JPRN-jRCT2080221862
- Lead Sponsor
- Zeria Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 260
Inclusion Criteria
Patients diagnosed with the following three types.
1. Zinc-deficient taste disorder
2. Idiopathic taste disorder
3. Drug-induced taste disorder (with some exceptions)
Exclusion Criteria
1. Central nervous system disorder
2. Peripheral neuropathy
3. Intraoral defect and salivary gland disorder
4. Psychiatric disorder
5. Systemic disorders that cause taste disorder
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Final overall efficacy evaluation<br>Filter-paper Disk Method
- Secondary Outcome Measures
Name Time Method Efficacy evaluation at each evaluation period<br>Filter-paper Disk Method